HilleVax, Inc. (HLVX)

Latest Insider Confidence Score

2025Q4

44.6
Bearish

Company insider confidence (by quarter)

2022Q2 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Socks David A — 769,055 Apr 28, 2022
Borkowski Astrid Chief Medical Officer 69,852 Feb 12, 2024
Silbermann Susan Michele — 25,000 Aug 23, 2022
McLoughlin Sean COO 1,250 Apr 1, 2024
Heron Patrick J Director 0 Sep 17, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 17, 2025 Sep 17, 2025 Frazier Life Sciences X, L.P. 10% Owner Sell 15.0 -8,552,536 -100.00% ✗ $16.7M
Sep 17, 2025 Sep 17, 2025 HERSHBERG ROBERT CEO Neutral 27.5 -1,101,498 -100.00% ✗ -
Sep 17, 2025 Sep 17, 2025 Cocero Nanette Director Neutral 27.5 -17,199 -100.00% ✗ -
Sep 17, 2025 Sep 17, 2025 HILLEMAN JERYL L Director Neutral 27.5 -59,224 -100.00% ✗ -
Sep 17, 2025 Sep 17, 2025 Chu Shelley Director Neutral 27.5 -17,199 -100.00% ✗ -
Sep 17, 2025 Sep 17, 2025 Dubin Gary Director Neutral 27.5 -17,199 -100.00% ✗ -
Sep 17, 2025 Sep 17, 2025 Kohli Aditya Director Neutral 27.5 -698,171 -100.00% ✗ -
Sep 17, 2025 Sep 17, 2025 Gerberding Julie L. Director Neutral 27.5 -59,224 -100.00% ✗ -
Sep 17, 2025 Sep 17, 2025 Maltbie Shane CFO Neutral 27.5 -83,738 -100.00% ✗ -
Sep 17, 2025 Sep 17, 2025 Sepulveda Jaime Director Neutral 27.5 -59,224 -100.00% ✗ -
Jun 23, 2025 Jun 25, 2025 Heron Patrick J Director Neutral 60.0 +17,199 0.20% ✗ -
Jun 23, 2025 Jun 25, 2025 Kohli Aditya Director Neutral 82.5 +17,199 2.53% ✗ -
Jun 23, 2025 Jun 25, 2025 Chu Shelley Director Neutral 90.0 +17,199 100.00% ✗ -
Jun 23, 2025 Jun 25, 2025 Sepulveda Jaime Director Neutral 90.0 +17,199 40.93% ✗ -
Jun 23, 2025 Jun 25, 2025 Cocero Nanette Director Neutral 90.0 +17,199 100.00% ✗ -
Jun 23, 2025 Jun 25, 2025 Gerberding Julie L. Director Neutral 90.0 +17,199 40.93% ✗ -
Jun 23, 2025 Jun 25, 2025 Dubin Gary Director Neutral 90.0 +17,199 100.00% ✗ -
Jun 23, 2025 Jun 25, 2025 HILLEMAN JERYL L Director Neutral 90.0 +17,199 40.93% ✗ -
Jun 6, 2024 Apr 30, 2025 Chu Shelley Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Apr 30, 2025 Cocero Nanette Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Apr 30, 2025 Gerberding Julie L. Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Apr 30, 2025 HILLEMAN JERYL L Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Apr 30, 2025 Sepulveda Jaime Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Apr 30, 2025 Heron Patrick J Director Neutral 52.5 - 0.00% ✗ -
Feb 4, 2025 Feb 12, 2025 HERSHBERG ROBERT Officer Sell 46.3 -26,535 -2.35% ✗ $48.7K
Feb 4, 2025 Feb 12, 2025 Maltbie Shane CFO Sell 46.3 -8,291 -9.40% ✗ $15.1K
May 31, 2024 Frazier Life Sciences X, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
May 20, 2024 May 22, 2024 Kohli Aditya Director Sell 38.8 -18,000 -2.30% ✓ $266.3K
May 1, 2024 May 3, 2024 Kohli Aditya Director Sell 47.5 -6,898 -0.87% ✓ $96.8K
Apr 4, 2024 Apr 8, 2024 Frazier Life Sciences X, L.P. 10% Owner Buy 60.0 +8,850 0.10% ✗ $128.3K
Apr 3, 2024 Apr 5, 2024 Kohli Aditya Director Sell 38.8 -18,000 -2.23% ✓ $264.5K
Mar 28, 2024 Apr 1, 2024 McLoughlin Sean COO Buy 91.3 +1,250 100.00% ✗ $21.2K
Mar 18, 2024 Mar 20, 2024 Kohli Aditya Director Sell 33.8 -18,000 -2.18% ✓ $985.5M
Mar 6, 2024 Mar 8, 2024 Kohli Aditya Director Sell 38.8 -18,000 -2.13% ✓ $335.9K
Feb 20, 2024 Feb 22, 2024 Kohli Aditya Director Sell 38.8 -18,000 -2.09% ✓ $269.1K
Feb 12, 2024 Feb 14, 2024 Kohli Aditya Director Sell 47.5 -6,000 -0.69% ✓ $91.9K
Feb 8, 2024 Feb 12, 2024 Kohli Aditya Director Sell 90.0 +46,032 5.60% ✗ $132.4K
Feb 8, 2024 Feb 12, 2024 Maltbie Shane CFO Sell 95.0 +43,946 99.35% ✗ $53.4K
Feb 8, 2024 Feb 12, 2024 HERSHBERG ROBERT Officer Sell 95.0 +162,605 16.84% ✗ $173.2K
Feb 8, 2024 Feb 12, 2024 Borkowski Astrid Chief Medical Officer Sell 95.0 +49,699 30.09% ✗ $58.7K
Jan 31, 2024 Feb 2, 2024 McLoughlin Sean COO Neutral 52.5 - 0.00% ✗ -
Jan 26, 2024 McLoughlin Sean COO Neutral 52.5 - 0.00% ✗ -
Dec 15, 2023 Dec 18, 2023 Borkowski Astrid Chief Medical Officer Sell 22.5 -10,000 -5.71% ✗ $155K
Dec 1, 2023 Dec 5, 2023 Borkowski Astrid Chief Medical Officer Sell 20.0 -20,000 -10.25% ✗ $287K
Nov 17, 2023 Nov 20, 2023 Borkowski Astrid Chief Medical Officer Sell 22.5 -10,000 -4.87% ✗ $140K
Nov 8, 2023 Nov 13, 2023 Borkowski Astrid Chief Medical Officer Sell 22.5 -5,000 -2.38% ✗ $65K
Jun 21, 2023 Jun 23, 2023 Borkowski Astrid Chief Medical Officer Sell 22.5 -10,000 -4.54% ✗ $161.1K
Jun 7, 2023 Jun 9, 2023 Chu Shelley Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 9, 2023 Cocero Nanette Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 9, 2023 Gerberding Julie L. Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 9, 2023 Sepulveda Jaime Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 9, 2023 HILLEMAN JERYL L Director Neutral 52.5 - 0.00% ✗ -
Jun 7, 2023 Jun 9, 2023 Heron Patrick J Director Neutral 52.5 - 0.00% ✗ -
May 8, 2023 May 10, 2023 Cocero Nanette Director Neutral 52.5 - 0.00% ✗ -
May 10, 2023 Cocero Nanette Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2023 Feb 3, 2023 Borkowski Astrid Chief Medical Officer Neutral 90.0 +51,333 30.48% ✗ -
Feb 1, 2023 Feb 3, 2023 Kohli Aditya COO Neutral 90.0 +85,466 11.61% ✗ -
Feb 1, 2023 Feb 3, 2023 HERSHBERG ROBERT CEO Neutral 90.0 +187,966 24.18% ✗ -
Feb 1, 2023 Feb 3, 2023 Maltbie Shane CFO Neutral 90.0 +43,333 4820.13% ✗ -
Jan 10, 2023 Maltbie Shane CFO Neutral 52.5 - 0.00% ✗ -
Aug 19, 2022 Aug 23, 2022 Gerberding Julie L. Director Neutral 52.5 - 0.00% ✗ -
Aug 19, 2022 Aug 23, 2022 Silbermann Susan Michele Director Neutral 52.5 - 0.00% ✗ -
Aug 19, 2022 Aug 23, 2022 Chu Shelley Director Neutral 52.5 - 0.00% ✗ -
Aug 19, 2022 Aug 23, 2022 HILLEMAN JERYL L Director Neutral 52.5 - 0.00% ✗ -
Aug 19, 2022 Aug 23, 2022 Sepulveda Jaime Director Neutral 52.5 - 0.00% ✗ -
Aug 19, 2022 Aug 23, 2022 Heron Patrick J Director Neutral 52.5 - 0.00% ✗ -
May 3, 2022 May 3, 2022 Frazier Life Sciences X, L.P. 10% Owner Buy 100.0 +1,764,706 26.06% ✗ $30M
Apr 28, 2022 Kohli Aditya COO Neutral 52.5 - 0.00% ✗ -
Apr 28, 2022 HILLEMAN JERYL L Director Neutral 52.5 - 0.00% ✗ -
Apr 28, 2022 Borkowski Astrid Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 28, 2022 Gerberding Julie L. Director Neutral 52.5 - 0.00% ✗ -
Apr 28, 2022 Dubin Gary Director Neutral 52.5 - 0.00% ✗ -
Apr 28, 2022 Sepulveda Jaime Director Neutral 52.5 - 0.00% ✗ -
Apr 28, 2022 Frazier Life Sciences X, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Apr 28, 2022 Socks David A CFO Neutral 52.5 - 0.00% ✗ -
Apr 28, 2022 Chu Shelley Director Neutral 52.5 - 0.00% ✗ -
Apr 28, 2022 HERSHBERG ROBERT CEO Neutral 52.5 - 0.00% ✗ -
Apr 28, 2022 Silbermann Susan Michele Director Neutral 52.5 - 0.00% ✗ -